Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
493.95
-1.91 (-0.39%)
Jul 28, 2025, 4:00 PM - Market closed
Intuitive Surgical Revenue
Intuitive Surgical had revenue of $2.44B in the quarter ending June 30, 2025, with 21.40% growth. This brings the company's revenue in the last twelve months to $9.15B, up 20.77% year-over-year. In the year 2024, Intuitive Surgical had annual revenue of $8.35B with 17.24% growth.
Revenue (ttm)
$9.15B
Revenue Growth
+20.77%
P/S Ratio
19.29
Revenue / Employee
$584,793
Employees
15,638
Market Cap
177.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.35B | 1.23B | 17.24% |
| Dec 31, 2023 | 7.12B | 901.90M | 14.49% |
| Dec 31, 2022 | 6.22B | 512.10M | 8.97% |
| Dec 31, 2021 | 5.71B | 1.35B | 31.01% |
| Dec 31, 2020 | 4.36B | -120.10M | -2.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| Novartis AG | 55.19B |
| AstraZeneca | 54.98B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ISRG News
- 6 days ago - Intuitive Surgical, Inc. (ISRG) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots - Reuters
- 6 days ago - Intuitive Announces Second Quarter Earnings - GlobeNewsWire
- 6 days ago - Intuitive Surgical: If You're Looking For A Dip To Buy, Get It Now (Rating Upgrade) - Seeking Alpha
- 18 days ago - Vessel Sealer Curved receives FDA clearance - GlobeNewsWire
- 26 days ago - Intuitive's da Vinci 5 Surgical System Receives CE Mark - GlobeNewsWire
- 6 weeks ago - Intuitive Surgical Stock: Why This Correction Is Healthy And What Lies Ahead - Benzinga
- 7 weeks ago - Intuitive Surgical stock dubbed a ‘premier, high-growth' name despite first sell rating - Invezz